Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.

J Urol 2020 Jan 3:101097JU0000000000000714. Epub 2020 Jan 3.

McMaster University, Hamilton.

Purpose: To describe the cardiovascular risk profile in a representative cohort of prostate cancer patients treated with or without androgen deprivation therapy (ADT).

Materials And Methods: We prospectively characterized in detail 2492 consecutive men (mean age 68 years) with prostate cancer (newly diagnosed or with a plan to prescribe ADT for the first time) from 16 Canadian sites. Cardiovascular risk was estimated by calculating Framingham risk scores.

Results: Most (92%) had new prostate cancer (intermediate-risk in 41%; high-risk in 50%). The highest level of education achieved was primary school in 12%. Most (58%) were current or former smokers; 22% had known cardiovascular disease; 16% diabetes; 45% hypertension; 31% body-mass index ≥30kg/m; 24% had low levels of physical activity; the mean handgrip strength was 37.3kg; 69% had a Framingham risk score consistent with high cardiovascular risk. Participants in whom ADT was planned had higher Framingham risk scores than those not intending to receive ADT; this risk was abolished after adjustment for confounders.

Conclusions: Two-thirds of men with prostate cancer is at high cardiovascular risk. There is a positive association between a plan to use ADT and baseline cardiovascular risk factors; however, this association is explained by confounding factors.

Download full-text PDF

Source
http://dx.doi.org/10.1097/JU.0000000000000714DOI Listing
January 2020

Publication Analysis

Top Keywords

cardiovascular risk
24
prostate cancer
20
framingham risk
12
risk
9
men prostate
8
high cardiovascular
8
cardiovascular
7
cancer
5
prostate
5
41% high-risk
4
education achieved
4
risk scores
4
higher framingham
4
intermediate-risk 41%
4
planned higher
4
adt planned
4
level education
4
cancer intermediate-risk
4
highest level
4
50% highest
4

Similar Publications